During the last session, Precigen Inc (NASDAQ:PGEN)’s traded shares were 0.81 million, with the beta value of the company hitting 1.67. At the end of the trading day, the stock’s price was $1.59, reflecting an intraday loss of -3.05% or -$0.05. The 52-week high for the PGEN share is $2.17, that puts it down -36.48 from that peak though still a striking 59.12% gain since the share price plummeted to a 52-week low of $0.65. The company’s market capitalization is $467.53M, and the average intraday trading volume over the past 10 days was 1.38 million shares, and the average trade volume was 2.06 million shares over the past three months.
Precigen Inc (PGEN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.80. PGEN has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
Precigen Inc (NASDAQ:PGEN) trade information
Precigen Inc (PGEN) registered a -3.05% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.05% in intraday trading to $1.59, hitting a weekly high. The stock’s 5-day price performance is -12.15%, and it has moved by -9.14% in 30 days. Based on these gigs, the overall price performance for the year is 13.57%. The short interest in Precigen Inc (NASDAQ:PGEN) is 22.66 million shares and it means that shorts have 12.62 day(s) to cover.
The consensus price target of analysts on Wall Street is $6, which implies an increase of 73.5% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6 and $6 respectively. As a result, PGEN is trading at a discount of -277.36% off the target high and -277.36% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 25.76%. While earnings are projected to return 42.98% in 2025.
PGEN Dividends
Precigen Inc is due to release its next quarterly earnings on 2025-Mar-18. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Precigen Inc (NASDAQ:PGEN)’s Major holders
Precigen Inc insiders own 9.97% of total outstanding shares while institutional holders control 66.16%, with the float percentage being 73.49%. PATIENT CAPITAL MANAGEMENT, LLC is the largest shareholder of the company, while 176.0 institutions own stock in it. As of 2024-06-30, the company held over 18.17 million shares (or 7.2017% of all shares), a total value of $28.72 million in shares.
The next largest institutional holding, with 10.25 million shares, is of BLACKROCK INC.’s that is approximately 4.0604% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $16.19 million.
Also, the Mutual Funds coming in first place with the largest holdings of Precigen Inc (PGEN) shares are Advisor Managed Portfolios-Patient Opportunity Trust and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . Data provided on Dec 31, 2024 indicates that Advisor Managed Portfolios-Patient Opportunity Trust owns about 14.4 shares. This amounts to just over 4.90 percent of the company’s overall shares, with a $22.9 million market value. The same data shows that the other fund manager holds slightly less at 5.45, or about 1.85% of the stock, which is worth about $8.67 million.
